Human behavior is driven by specific neuronal activity and can be directly associated to characteristic brain states. The oscillatory activity of neurons contains information about the mental state of an individual, and the transition between different brain states is controlled by the neuromodulatory action of acetylcholine on nicotinic and muscarinic receptors. Manipulating brain waves bears high therapeutic interest in several neurological disorders, and can be achieved by transcranial direct current and magnetic stimulation techniques, and by optogenetics, although the clinical translation of the latter is hampered by the need of gene therapy. Here, we directly modulate brain waves with light using a photoswitchable muscarinic agonist. Synchronous slow wave activity can be disrupted in isolated cortical slices and in anesthetized mice. These results open the way to study the spatiotemporal distribution and the pharmacology of brain states, their transitions, and their links to cognition and behavior, in a diversity of wildtype organisms.
INTRODUCTION
All behaviors, thoughts, and emotions are rooted in the communication between the billions of neurons that constitute the brain. [1] [2] [3] Individual neurons transmit information using chemical and electrical signals, and are organized in groups or "circuits" that carry out a certain function. [3] [4] [5] The electro-chemical interactions of these groups of neurons produce synchronized electrical activity in the brain, called "brain waves" due to their periodic and propagating properties. [6] [7] [8] They can be recorded by electroencephalography (EEG), and local field potential (LFP) measurements. Brain waves, their frequency and other characteristic parameters, are associated to internal brain states and result in specific behaviors. 1 The entirety of neuronal activity undergoes important changes during brain and behavioral state transitions, which have been linked to strong changes in the EEG pattern activity. 9 For example, large and synchronous brainwaves are mostly associated with deep sleep, whereas wakefulness shifts them toward more desynchronized and shortamplitude wave patterns. 7, 10, 11 These changes in brain and behavioral states, and the concomitant alterations in EEG activity, can be driven by the action of neuromodulators like acetylcholine (ACh). 9, 12 However, it is not known how the different cells expressing ACh receptors contribute to altering the global cortical state. Cholinergic receptors include nicotinic ion channels and muscarinic G protein-coupled receptors. Together, they modulate cortical activity on a fine spatial scale and are involved in crucial neocortical functions such as attention, 13, 14 learning, [15] [16] [17] memory, 18 and sensory and motor functions. 19, 20 In the neocortex, ACh is released mostly at cholinergic afferents from neurons distributed within the basal forebrain (BF) nuclei. Electrical stimulation of nucleus basalis can evoke the release of ACh in the neocortex but in an unselective manner, as ascending projections from BF nuclei not only comprise cholinergic axons, but also GABAergic and glutamatergic axons. 21 Such lack of selectivity complicates the study of cholinergic signaling in neocortex and its effects on controlling brain states.
Selective stimulation of cholinergic projections in the neocortex from BF nuclei has been demonstrated with optogenetics, which enables disrupting neocortical synchronous activity during certain sleep states. Optogenetic stimulation of BF cholinergic neurons also revealed their influence in awake cortical dynamics, coding properties of V1 neurons, and the importance of cholinergic neuromodulation for visual discrimination tasks, showing that stimulation of BF cholinergic cells activates cortical transitions faster than presumed. 10 However, the cell type specificity of optogenetics is limited by the availability of suitable promoters. In addition, it is based on the overexpression of microbial proteins using genetic manipulation, which raise safety and regulatory concerns when therapeutic applications are considered.
The control of neuronal signalling with photopharmacology is based on synthetic ligands that target endogenous proteins, and thus its physiological relevance spans from the circuits to the sub-cellular levels. For the same reason, photoswitchable ligands can generally be used in multiple species, and their safety and regulation can be established as for other drugs. Since the cholinergic system is key to modulate various CNS functions, 22 the use of selective and photoswitchable cholinergic drugs to spatiotemporally control cortical activity would have relevant scientific and clinical implications. Herein, we report that the cholinergicdependent brain state transitions in the neocortex can be directly controlled using Phthalimide-Azo-Iper (PAI) 23 a photoswitchable agonist that targets M2 muscarinic acetylcholine receptors (mAChRs) without requiring electric or genetic manipulation. In particular, PAI enables modulating spontaneous emerging slow oscillations (SO) in neuronal circuits. PAI cis-to-trans photoisomerization decreases the Down-and Up-state durations, and increases the oscillatory frequency in cortical slices. In addition, PAI allows reversibly manipulating the cortical oscillation frequency in anesthetized mice using light. Thus, photopharmacology allows for the first time selectively controlling SO in vitro and in vivo, opening the way to dissect their spatiotemporal dynamics and their effects on brain and behavioural state transitions.
RESULTS

Non-specific activation of mAChRs evokes neuronal hyperexcitability in cortical slices
Alterations in cortical rhythms underlie behavioral state transitions, and neuronal ACh actions play central roles in such variations. [24] [25] [26] [27] [28] [29] [30] However, a complete and unifying view has not yet emerged 11 about the cholinergic impact on neuronal and synaptic physiology, and thus on neocortical network dynamics. It is known that ACh shifts the neocortical network state from a synchronous to asynchronous activity in a dosedependent manner, but the activity of ACh on the vast majority of neocortical neurons and synapses is poorly characterized. Neocortical activation of mAChRs in vitro facilitates synaptic transmission, 31 recurrent excitation, 32 and reversibly increases the power of fast-frequency oscillations. [33] [34] [35] [36] On this basis, we first studied in vitro the effect of Iperoxo, a potent muscarinic agonist. 37 The goal was to evaluate the potential of mAChRs to selectively modulate the dynamics of isolated V1 cortical slices, while avoiding the simultaneous activation of nicotinic cholinergic receptors (nAChRs), and to validate Iperoxo photoswitches and useful photopharmacological tools to control neuronal activity. Isolated cortical slices spontaneously generate cortical SO, a hallmark of activity during deep sleep or anesthesia. 38 We recorded the spontaneous oscillatory activity (control) and then under different concentrations (1, 10, 100 nM) of Iperoxo. Slow wave activity alternates periods of activity or high neuronal firing (Up state) and periods of near silence (Down state). The activation of mAChRs by Iperoxo resulted in a global change in the network's dynamics to an hyperexcitable activity ( Fig. 1) . At 100 nM Iperoxo, the OF increased (from 0.89 ± 0.12 Hz in the control, to 1.34 ± 0.18 Hz with 100 nM Iperoxo), and the relative firing rate of the Up-states decreased (from 1.13 ± 0.23 a.u. to 0.10 ± 0.02 with 100 nM Iperoxo) ( Fig. 1B) . In addition, at concentrations equal or higher than 100 nM Iperoxo, the oscillatory activity evolved to periods of seizure-like discharges (Fig.1C ), 39, 40 characterized by low (<1 Hz), delta (1-4 Hz) and alfa (8) (9) (10) (11) (12) Hz) frequencies ( Fig. 1D ). 
Effect of PAI isomers on slow and fast oscillations in vitro
The hyperexcitable activity obtained with Iperoxo reflects the role of mAChRs activation in cortical networks and brain states. 11 In order to remotely control these states, we aimed at the observed muscarinic neuromodulation using PAI, a photoswitchable Iperoxo derivative that allows reversibly activating M2 mAChRs with light. 23 M2 receptors play relevant roles in several CNS disorders, 22 and regulating their activity and subsequent effects on cortical neuronal networks may provide new therapeutic opportunities for these cholinergic diseases.
Taking advantage of its profile as M2 light-regulated agonist, we studied its effect on the modulation of neuronal oscillations in cortical slices, as M2. Thus, we applied PAI and illumination to brain slices and recorded their oscillatory activity. We first built up the dose-response curves of the two drug forms separately, trans-(dark-adapted state) and cis-PAI (after UV irradiation), in order to find out the differences in cortical activity between the PAI-isoforms, and to identify the most convenient concentration range to manipulate brain waves with light. The baseline activity (characterized by SO) was recorded as a control, prior to bath-application of solutions with increasing PAI concentrations (10 nM, 100 nM, 300 nM, and 1 µM, n = 6 for each PAI form, trans and cis) ( Fig. 2A) . Comparing to the control situation, the trans-PAI activity showed alterations in the Up-and Down-state sequence already at 100 nM ( Fig.2) , leading an increment in the OF (from 0.58 ± 0.06 Hz during control to 1.87 ± 0.12 Hz applying 1 µM trans-PAI) ( Fig. 2B) . Moreover, increasing concentrations of trans-PAI decreased the relative firing rate during the Up states (from 0.98 ± 0.11 a.u. during control to 0.37 ± 0.03 a.u. with 1 µM trans-PAI) (Fig. 2C, D) . In comparison, cis-PAI displayed significantly weaker effects, in agreement with the reported PAI properties. 23 At 100 nM and 300 nM, cis-PAI did not alter the spontaneous activity observed in control experiments (control OF: 0.48 ± 0.037 Hz; 100 nM cis-PAI OF: 0.52 ± 0.07 Hz; 300 nM cis-PAI OF: 0.87 ± 0.2 Hz), in contrast to the strong alterations in oscillatory activity obtained with 100 nM and 300 nM trans-PAI (Fig. 2) . Only at concentrations as high as 1 µM, cis-PAI altered the Up-and Down-state sequence in comparison to the control, increasing the OF (1.32 ± 0.27Hz) and decreasing the relative firing rate of the Up-states (from 0.86 ± 0.04 a.u. during control to 0.74 ± 0.27 a.u. with 1 µM cis-PAI) (Fig. 2C, D) . In summary, the most interesting differences between transand cis-PAI emerged between 100 nM and 300 nM, and were observed in the OF (Hz) and Up-states relative firing rate (a.u.) ( Fig. 2) . We focused on these conditions in order to photomodulate cortical SO using PAI. 
PAI effectively modulates cortical SO in vitro
Once the different oscillatory activity evoked by cisand trans-PAI was quantified in vitro ( Fig.2 ), we moved on to control SO activity with light in the same cortical slices ( Fig.3 ). We took advantage of the thermal stability of both PAI forms to apply initially the inactive one (cis-PAI) at 200 nM in cortical slices (n = 15), in the absence of white light to avoid photoconversion to trans-PAI during the recordings. 23 As shown in Fig.2 , 200 nM cis-PAI evoked minor changes in OF (from 0.53 ± 0.04 Hz in control conditions to 1.04 ± 0.14 Hz with cis-PAI), and no significant effects in the relative firing rate of the Up-states (from 0.98 ± 0.09 a.u. in the control to 0.86 ± 0.10 a.u. with cis-PAI) (Fig. 3) . Subsequent illumination of the slices with white light produced a robust increase in OF (from 0.53 ± 0.04 Hz in the control to 1.68 ± 0.13 upon illumination), a decrease in relative firing rate of the Up-states (control: 0.98 ± 0.09 a.u.; white light: 0.52 ± 0.06 a.u.), and an increment of the power of delta (1-4 Hz) and theta (4-7 Hz) bands after light activation of PAI (trans) (Fig. 3) . These changes are similar to the effects of adding Iperoxo to the bath (Fig. 1) , and in agreement with PAI photoconversion to the active form (trans). The modification in cortical activity was not reversible with 365 nm light (to isomerize PAI to the cis form in situ), due either to the irreversibility of muscarinic stimulation in the absence of BF afferents and other circuit components in brain slices, or to neuronal damage produced by UV light. 
PAI can modulate brain wave activity with light in vivo
Having established the unique ability of PAI to alter cortical oscillatory activity with light in slices, we aimed at photocontrolling brain state transitions in vivo. Cortical brain waves were recorded in C57BL6/JR mice (n = 4) with a tungsten electrode inserted through a craniotomy that also enabled drug application and brain illumination (see Methods). Initially, we induced deep anesthesia in the animals, a state that is known to reproduce the slow wave sleep state, 25, 26, 41 and which is characterized by the generation of cortical SO similar to the slow frequency waves observed in our experiments in slices under control conditions ( Fig.1-3 ). 6 Such SO activity in anesthetized mice was recorded for 500 s under white light illumination of the brain, and the characteristic parameters obtained (OF 0.64 ± 0.06 Hz, relative firing rate 0.83 ± 0.23 a.u.) were taken as the control condition in vivo. As the dose-response curves of cisand trans-PAI could be different from the in vitro conditions (Fig. 2) , we tested two different concentrations, 200 nM and 1 µM. 100 µL of 200 nM cis-PAI solution were initially applied to the brain surface, and the activity was recorded for another 500 s in the absence of white light, to avoid cis to trans photoisomerization of PAI. The frequency of the cortical oscillatory activity was not significantly altered by cis-PAI (0.61 ± 0.06 Hz), and caused a minor increase of the relative firing rate (1.02 ± 0.31 a.u.). Subsequently, we illuminated the brain using white light in the proximity of the tungsten electrode, in order to isomerize PAI to its active form (trans), and recorded the activity for another 500 s . An increase in OF to 0.76 ± 0.1 Hz was observed under white light illumination, without changes in the relative firing rate (1.04 ± 0.27 a.u.). Applying a higher concentration of cis-PAI (1 µM) slightly reduced the OF to 0.61 ± 0.1 without affecting the relative firing rate (0.99 ± 0.27 a.u.), and produced stronger effects on the cortical activity with light: the OF rose to 0.83 ± 0.06 Hz and the relative firing rate decreased to 0.86 ± 0.19 a.u. (Fig. 4) . This allowed repeating twice the photocontrol of cortical activity by subsequent application of 1 µM cis-PAI and photoconversion to trans-PAI. 
DISCUSSION
Different brain states are associated with distinct behaviors. In order to investigate the causality between them, behavioral outcomes must be correlated with the spontaneous and evoked activity in the cortical network. Thus, understanding the mechanisms of brain and behavioral state transitions requires new techniques to manipulate neuronal activity. 1 They must enable the activation and inhibition of specific brain areas and neuronal circuits defined by several complementary criteria, namely electrical stimulation in selected regions, and photomanipulation that is cell-specific, or neurotransmitter-specific (using optogenetic and photopharmacology, respectively).
Modulation of brain waves is also therapeutically useful to treat CNS diseases, as shown by pioneering techniques to control cortical activity noninvasively based on electromagnetic stimulation. 42, 43 Transcranial current stimulation enhances motor learning capacity in humans by cross-modulating the oscillatory neural activity (alpha and beta frequencies) in the motor cortex. [44] [45] [46] [47] [48] Transcranial magnetic stimulation can normalize excessive gamma oscillations in the prefrontal cortex, and restore cognitive performance in patients with schizophrenia, Alzheimer's and Parkinson's diseases, 49, 50 and anxiety disorders. 51, 52 However, the physiological mechanisms of brain wave modulation are not known, and they are essential to improve its spatiotemporal and spectral performance, both for fundamental and therapeutic purposes. 53 Optogenetics 54,55 has emerged as an alternative to controlling brain waves with electromagnetic fields: photocontrolling the release of ACh, which strongly modulates the transitions between different brain states, 9, 12 is possible by overexpressing photosensitive proteins in cholinergic neurons of mice neocortex. 10, 56, 57 However, genetic manipulation is required in this approach, and our light-dependent cholinergic muscarinic ligand is so far the only way to directly photomodulate cholinergic pathways in intact tissue. We first studied the effect of the superagonist Iperoxo 37 on isolated cortical slices ( Fig. 1 ) in order to demonstrate that deep-sleep brain states can be controlled by selectively manipulating muscarinic receptors at their physiological location and context. The oscillatory frequency of the network was greatly increased already at 100 nM Iperoxo, and lead to periods of seizure-like discharges, in agreement with previous studies performed by knockout mice and pilocarpine 39, 40 in which pathologic activation of muscarinic acetylcholine receptors induced seizures. Photocontrol of muscarinic signaling was subsequently achieved in vitro and in vivo with the photochromic iperoxo derivative PAI, 23 which is targeted allosterically at M2 subtype receptors ( Fig. 2-4) . In particular, PAI is a dualsteric ligand displaying full agonism, which is probably important to achieve effective photocontrol in slices, where axons from cholinergic afferents have been cut and the concentration of ACh can be assumed to be zero due to the degradation by extracellular esterases. M2 mAChRs are involved in several CNS diseases like major depressive 22, 58 and bipolar disorders, 22, 59 Parkinson's 22, 60, 61 and Alzheimer´s 22,61,62 diseases, but also in alcohol, smoking and drug dependence. 22, 63, 64 These disorders are thus susceptible to drug-based photomodulation in vivo without requiring genetic manipulation. Although PAI cannot cross the blood-brain barrier due to its charge, and its safety profile has not been systematically characterized, it is less likely to trigger immune reactions and mutagenesis than microbial opsins.
In summary, the manipulation of brain state transitions, by means of photocontrolling the frequency of cortical oscillations, has been achieved with a photoswitchable dualsteric agonist of M2 mAChRs. This result opens the way to (1) dissecting the spatiotemporal distribution and pharmacology of brain states, namely how they depend on agonists, antagonists, and modulators of the different muscarinic subtypes expressed in the CNS, and (2) investigating the neuronal dynamics that regulate brain state transitions in the cortical surface and beyond. In particular, two-photon stimulation of PAI using pulsed infrared light 23 offers the promise of subcellular resolution in three dimensions, as recently demonstrated with endogenous mGlu 5 . 65 Compared to the local and often inhomogeneous expression patterns achieved with viral injections of optogenetic constructs, diffusible small molecules like PAI can be in principle applied to larger brain regions to control neuronal oscillations. 57 Thus, remote control of brain waves based on the photopharmacological manipulation of endogenous muscarinic receptors may reveal the complex 3D molecular signalling underlying brain states and their transitions, in order to link them with cognition and behavior in a diversity of wildtype organisms.
EXPERIMENTAL PROCEDURES Slice Preparation
Twenty-five ferrets (4-to 6-month-old) were anesthetized with sodium pentobarbital (40 mg/kg) and decapitated. The entire forebrain was rapidly removed and placed in oxygenated cold (4-10 °C) bathing medium. 38 Ferrets were treated in accordance with protocols approved by the Animal Ethics Committee of the University of Barcelona, which comply with the European Union guidelines on protection of vertebrates used for experimentation (Directive 2010/63/EU of the European Parliament and the Council of 22 September 2010). Coronal slices (400 µm thick) from primary visual cortex (V1) were used. 66 To increase tissue viability we used a modification of the sucrose-substitution technique. 67 During slice preparation, the tissue was placed in a solution in which NaCl was replaced with sucrose while maintaining the same osmolarity. After preparation, the slices were placed in an interface-style recording chamber (Fine Sciences Tools, Foster City, CA, USA). During the first 30 min the cortical slices were superfused with an equal mixture in volume of the normal bathing medium, artificial cerebral spinal fluid (ACSF) and the sucrose-substituted solution. Following this, normal bathing medium was added to the recording chamber and the slices were superfused for 1-2 h; the normal bathing medium contained (in mM): NaCl, 126; KCl, 2.5; MgSO 4 , 2; Na 2 HPO 4 , 1; CaCl 2 , 2; NaHCO 3 , 26; dextrose, 10; and was aerated with 95% O 2 , 5% CO 2 to a final pH of 7.4. Then, a modified slice solution was used throughout the rest of the experiment; it had the same ionic composition except for different levels of the following (in mM): KCl, 4; MgSO 4 , 1; and CaCl 2 , 1. 38 Bath temperature was maintained at 34-36 °C.
Drug application and photostimulation in brain slices
Iperoxo and PAI, both prepared as previously reported from commercially available starting materials, 23 were bath-applied at the concentrations range of 1 nM to 100 nM for Iperoxo and 10 nM to 1 uM for PAI, as it is mention in Results section. We usually waited more than 1000 s after the application of the drug in order to let it act and to obtain a stable pattern of electrical activity, and to ensure a stable concentration in the bath. PAI effectively photomodulates the activity of M2 receptors in vitro and in vivo: in its dark-adapted state (trans form) behaves as a strong M2 agonist, then upon illumination with UV light (365 nm), PAI switches to its off-state (cis form). PAI can be switched back to its on-state with blue or white light, or using 2 photon excitation with pulsed NIR light. 23 The high thermal stability of PAI inactive form (cis isomer) allows administering the inactive drug and subsequently activating M2 receptors in the target region with white light. 23 We first investigated the efficacy of PAI in cortical neuronal circuits in vitro by obtaining the doseresponse curves of transand cis-PAI solutions applied separately. The more active PAI isomer (trans) was tested by applying its dark-adapted form (87 % of trans-PAI), and cis-PAI was obtained by illuminating 1 mM stock solutions with 365 nm light for 10 min (73% of cis-PAI). 23 Increasing concentrations of both transand cis-PAI (10 nM, 100 nM, 300 nM and 1 µM) were bath applied in order to build up the dose-response curves.
LFP recording and data analysis from in vitro recordings
LFP recordings started after allowing at least 2 h of recovery of the slices. Extracellular multiple unit recordings were obtained with flexible arrays of 16 electrodes arranged in columns as in Figure (Figure 1A) . The multielectrode array (MEA) covered most of the area occupied by a cortical slice. It consisted of 6 groups of electrodes positioned to record electrophysiological activity from superficial and from deep cortical layers (692 μm apart) and from what should correspond to 3 different cortical columns (1500 μm apart). The unfiltered field potential (raw signal) was acquired at 10 kHz with a Multichannel System Amplifier (MCS, Reutlingen, Germany) and digitized with a 1401 CED acquisition board and Spike2 software (Cambridge Electronic Design, Cambridge, UK). The multiunit activity (MUA) was estimated as the power change in the Fourier components at high frequencies from the recorded LFP. 68 Up-state detection was performed by setting a threshold in the log(MUA) time series as previously described to quantify frequency of the slow oscillations. 6, 69 Relative firing rate (FR) of the Up-states were quantified from the transformed log(MUA) signal as mean of absolute value of log(MUA). To study the variability of power spectral densities (PSD) of the local field potential, we used Welch's method with 50% overlapped Hamming window with a resolution of 1 Hz. All off-line estimates and analyses were implemented in MATLAB (The MathWorks Inc., Natick, MA, USA). All variables in the experimental conditions were compared with the control (no chemical added) condition.
The in vivo preparation
Cortical electrophysiology experiments were carried out in 2-3 months old C57BL6/JR mice (n = 4) in accordance with the European Union Directive 2010/63/EU and approved by the local ethical committee. Mice were kept under standard conditions (room temperature, 12:12-h light-dark cycle, lights on at 08:00 a.m). Anesthesia was induced by intraperitoneal injection of ketamine (30 mg/kg) and medetomidine (100 mg/kg). After this procedure, the mouse was placed in a stereotaxic frame, and air was enriched with oxygen. Body temperature was maintained at 37°C throughout the experiment. 6 Slow and fast rhythms generated in the cerebral cortex of the anesthetized mouse. 70 Slow and fast neocortical oscillations in the senescence-accelerated mouse model SAMP8. Frontiers in aging neuroscience, 9, 141) . Craniotomy was made in each mouse: AP −2.5 mm, L 1.5 mm (primary visual cortex, V1). 71 Cortical recordings were obtained from infragranular layers with 1-2 MΩ single tungsten electrode insulated with a plastic coating except for the tip (FHC, Bowdoin, ME, USA). Spontaneous local field potential (LFP) recordings from V1 area provide information about the local neuronal population activity-within 250 μm. 72 MUA estimation, Up-state detection and quantification of relative FR was performed as previously described. All these parameters were used to compare spontaneous activity during anesthesia (control), after application of the preilluminated, inactive drug form (cis-PAI) and application of white light to activate the drug (trans-PAI). Cis-PAI was locally delivered to the cerebral cortex surface and activity was recorded while applying a commercial red filter on the white light source to avoid the activation of the drug. The uncovered brain was illuminated with a white light source (Photonic Optics™ Optics Cold Light Source LED F1) in order to in situ activate the drug (trans-PAI). The electrophysiological signal was amplified with a multichannel system (Multi Channel Systems), digitized at 20 kHz with a CED acquisition board and acquired with Spike 2 software (Cambridge Electronic Design) unfiltered. 70 
